Cti Biopharma reported $15.79M in Current Liabilities for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Applied Genetic Technologies AGTC:US $ 19.71M 3.16M
Baxter International BAX:US $ 3344M 157M
Bristol Myers Squibb BMY:US $ 18991M 1661M
Cti Biopharma CTIC:US $ 15.79M 0.23M
Cytori Therapeutics CYTX:US $ 8.35M 0.04M
Eli Lilly And LLY:US $ 15093.2M 3379M
Geron GERN:US $ 37.01M 8.46M
Mirati Therapeutics MRTX:US $ 180.87M 103.76M
Northwest Biotherapeutics NWBO:US 360.71M 2.7M
Novartis NOVN:VX SF 29633M 527M
Novartis NVS:US $ 29633M 527M
Seattle Genetics SGEN:US $ 433.83M 44.22M
Sunesis Pharmaceuticals SNSS:US $ 6.95M 0.69M
Teva Pharmaceutical Industries TEVA:US $ 12691M 602M
YTE INCY:US $ 660.32M 36.44M